Product & event news - Gerresheimer

Product & event news

Gerresheimer AG and Nelson Labs NV announce strategic alliance regarding Extractables and Leachables lab testing for the Pharmaceutical and Biotech Industries
To accelerate and de-risk drug development, Gerresheimer AG and Nelson Labs NV announce a formal strategic partnership on analytical and drug…
Read more
CPHI Frankfurt: DropControl – Gerresheimer´s solution for new ophthalmic formulations
Duesseldorf/Vaerloese, October 26, 2022. With DropControl, Gerresheimer has developed a new dropper insert for modern drugs with low viscosity for…
Read more
The Gx InnoSafe safety syringe is the first syringe with a passive needle protection system. In addition to the safety features, it can be processed on all existing filling lines without any additional preparation or assembly steps.
Duesseldorf/Buende, October 05, 2022. Nurses are among the occupational groups with the most frequent cuts and puncture wounds. This can lead to…
Read more
Gerresheimer at Connect In Pharma: Safely package and administer biotech and pharmaceutical products
Düsseldorf, September 06, 2022. At the premiere of Connect In Pharma, which takes place on September 14 and 15 in Geneva (Palexpo), Gerresheimer…
Read more
Gerresheimer Boleslawiec S.A. celebrates its 70th anniversary
Boleslawiec, August 22, 2022. On August 27, Gerresheimer Boleslawiec S.A. celebrates its 70th anniversary in Poland. Founded in 1952, the industrial…
Read more
At the Tettau plant Gerresheimer employs around 600 people and produces over 700 million glass containers a year.
Düsseldorf/Tettau, July 26, 2022. As part of its global sustainability strategy, the Gerresheimer Group has set itself the goal of reducing its CO2…
Read more
EcoVadis Gold
Duesseldorf, July 11, 2022 - Gerresheimer has been awarded the gold medal for the first time by EcoVadis, one of the leading providers of…
Read more
MRX003: a capsule dry powder inhaler
MERXIN and Gerresheimer worked successful together to realize the shortest possible time to market for the MERXIN MRX003 Capsule DPI Wackersdorf,…
Read more
ISR signs agreement with Gerresheimer for clinical-scale production of IcoOne nasal inhalers
Wackersdorf, May 30, 2022: The drug development company ISR has signed an agreement with Gerresheimer for large-scale production of the IcoOne nasal…
Read more

Contact us!

Communication & Marketing
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com

Press
Phone: +49 211 61 81 246
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com